Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04019522 · ClinicalTrials.gov registry record · NA
American Heart Association- Stroke/Hypoxia Study
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04019522 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 16 participants.
The verdict
NCT04019522, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Of the 795,000 people who experience a stroke every year in the US, only a small percentage will achieve full recovery. While current therapies promote strength and endurance, none directly address the unique potential of the brain to reorganize following injury. The goal of this project is to explore the effects of a novel therapy, acute intermittent hypoxia (AIH). During this therapy, individuals receive brief bouts of reduced oxygen levels by inhalation through a face mask. (This is akin to being on top of a tall mountain). In brief exposures, AIH is known to trigger the release of specific proteins that help the brain adapt to oxygen reductions. Published results in people with incomplete spinal cord injury have shown that AIH enhances muscle strength and coordination rather quickly. The research team aims to study the effects of AIH in stroke survivors.
Interventions
- OTHER Acute Intermittent Hypoxia (AIH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04019522
The ClinicalTrials.gov registry entry for NCT04019522 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acute Intermittent Hypoxia (AIH) is the first listed.
NCT04019522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04019522 about?
NCT04019522 is a clinical study titled "American Heart Association- Stroke/Hypoxia Study". Of the 795,000 people who experience a stroke every year in the US, only a small percentage will achieve full recovery. While current therapies promote strength and endurance, none directly address the unique potential of the brain to reorganize following injury. The goal of this project is to explo...
What is the current status of trial NCT04019522?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-07-15. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT04019522?
The interventions under investigation include: Acute Intermittent Hypoxia (AIH) (OTHER).
Who is sponsoring clinical trial NCT04019522?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.